Debut Biotech is a biotechnology company that harnesses nature, science, and creativity to develop sustainable beauty products and cosmetic active ingredients through breakthrough technology and human-centered brand innovation.

Joshua Britton

Debut Biotech

Cinegy provides software solutions for broadcast and media production, self-described as offering software defined television services.

Cinegy

Enginzyme develops enzyme immobilization technology for clean and efficient biomanufacturing as a self-described approach to meet sustainability goals in the chemical industry.

Robin Chatterjee

Samuel Hargestam

Karim Engelmark Cassimjee

Enginzyme

Teal provides tools for individuals to enhance their job search efforts, including a resume builder, job application tracker, and insights into job opportunities. Self-described as a personal career development platform.

Teal

Debut is an unconventional innovation company, integrating breakthrough biotechnology and brand creation to build businesses that represent the next generation of sustainable wellness. With proprietary screening, testing and cell-free biomanufacturing technology, we unlock novel actives to power global personal care and health brands. Our mission is to set a new standard for big business through our dynamic intrapreneurial model and to create purposeful brands that push humanity forward.

Air Force Research Laboratory

Springtide Ventures

KdT Ventures

Better Ventures

Cantos

FTW Ventures

ACVC Partners

Material Impact Fund

Cultivian Sandbox Ventures

Fine Structure Venture

Humboldt Fund

Business Opportunities for L'Oréal Development

Cavallo Ventures

GS Futures

Debut

Thank you very much to Kelly Kovack and BeautyMatter for publishing my opinion piece on clean beauty titled: “In Beauty, The Opposite of Clean is Not Dirty, It’s Science”.

Unlike clean beauty, which is riddled with cleanwashing claims, there can be no “biotech-washing” with biotech beauty. Biotechnology is underpinned by science, rigorous clinical testing, and manufacturing standards that have pharma-like precision and data credibility. There is zero margin for marketing interpretation or spin.

Moreover, the regulatory landscape will always favor biotech over cultivation or petroleum-based methods because safety, purity, consistency, and quality are hardwired in the way we manufacture ingredients.

We are entering a new era in beauty that has no place for cleanwashing.

Biotechnology is beauty’s new frontier and Debut is leading the next industrial transformation in beauty!

#biotechnology #biotechbeauty #beautyindustry #cleanbeauty #sustainability #beauty #innovation #skincare #cosmetics #futureofbeauty #precisionbeauty #sciencebackedbeauty


Inflammaging is the latest focus in skin aging.

https://lnkd.in/eSmDKSKM

#skincare #agingwell #beautyinnovation 

Meet Naringenin, our biotech cosmetic active superstar.

Thank you Global Cosmetic Industry for the great profile.

https://lnkd.in/egPx6QeC

Thank you WWD and Noor Lobad for the thoughtful piece on our launch - we are so honored to be profiled!

https://lnkd.in/eYi4RE6y

#beautyinnovation #skincare #launch 

Metric
Company Name	Debut Biotech	Cinegy	Enginzyme	Teal
Symbol
MSH ID	COM:DEBUTBIOTECH	COM:CINEGY	COM:ENGINZYME	COM:TEALHQ
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology	Technology	Commercial & Professional Services
Industry	Biotechnology	Media and entertainment	Biotechnology	Employment Services
Country	US	US	DE	US
Stage
Employee Count	85		57
Website	debutbiotech.com	cinegy.com	enginzyme.com	tealhq.com
LinkedIn	debutinnovation	cinegy-gmbh
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.28K	4.38K
Web Traffic Growth	-0.48	0.20
Valuation
Raised Capital		750K

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:DEBUTBIOTECH

Debut Biotech

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue